Ισραήλ - Αραβικά - Ministry of Health

dexcel ltd - omeprazole 20 mg - caplets - omeprazole - acute duodenal ulcer. acute gastric ulcer. reflux esophagitis: treatment , long - term management. maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcers or erosions in high risk patients. treatment of severe reflux oesophagitis in children overthe age of 6 year. helicobacter pylori - associated peptic ulcer disease in combination with antibiotics.

Ισραήλ - Αραβικά - Ministry of Health

dexcel ltd - metformin hydrochloride 850 mg - caplets - metformin - treatment of non-insulin diabetes mellitus not responding to dietary modification.

Ισραήλ - Αραβικά - Ministry of Health

teva pharmaceutical indust.ltd - repaglinide 1 mg - tablets - repaglinide - treatment of type ii diabetes.

Ισραήλ - Αραβικά - Ministry of Health

teva pharmaceutical indust.ltd - atenolol 100 mg - tablets - atenolol - management of angina pectoris and hypertension,including hypertension of renal origin. late intervention after acute myocardial infarction.

Ισραήλ - Αραβικά - Ministry of Health

abic ltd. - atenolol 50 mg - tablets - atenolol - management of angina pectoris and hypertension, including hypertension of renal origin. late intervention after acute myocardial infarction

Ισραήλ - Αραβικά - Ministry of Health

dexcel pharma technologies ltd - losartan potassium 50 mg - tablets - losartan - hypertension: losardex is indicated for the treatment of hypertension. heart failure: losardex is indicated for the treatment of heart failure (nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to losardex is not recommended. renal protection in type-2 diabetic patients with proteinuria: losardex is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease (need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventric

Ισραήλ - Αραβικά - Ministry of Health

teva pharmaceutical indust.ltd - mupirocin 2 % - ointment - mupirocin - acute primary bacterial skin infections susceptible to the drug e.g. impetigo and folliculitis.

Ισραήλ - Αραβικά - Ministry of Health

abic ltd. - sulphadiazine silver 1 % - cream - silver sulfadiazine - treatment of infected burn wounds, leg ulcers and pressure sores.

Ισραήλ - Αραβικά - Ministry of Health

teva pharmaceutical indust.ltd - diflucortolone valerate 0.1 %; isoconazole nitrate 1 % - cream - diflucortolone - for the local treatment of inflammatory skin conditions accompanied by secondary fungal infections.

Ισραήλ - Αραβικά - Ministry of Health

abic ltd. - chloramphenicol 3 %; prednisolone 0.5 % - ointment - prednisolone - infected eczema, pruritic lesions, angular stomatitis, impetigo, external otitis and pyoderma and other skin infections caused by chloramphenicol susceptible organisms.